Crain's: Man who received ALS stem cell transplant still doing well
Ted Harada, a 40-year-old man diagnosed with ALS, who received stem cell implantations to his spinal cord in two separate surgeries as part of the first-ever FDA-approved trial of a stem cell therapy for ALS, talked last week with Crain's Detroit business reporter Tom Henderson. Harada said he's still feeling the positive effects he attributes to his second surgery, which took place last August.
"I've been doing great and feeling great." Harada told Henderson. "Just now, the left leg showed a little bit of weakness returning, but I'm still so much better than I was before the surgeries. It's the first time, since August, they've noticed any slight weakness.
"It's clear from the data that the injections reversed my symptoms and slowed down the progression of the disease. I've received a blessing. I almost forget I have ALS. I don't have the constant reminder of having to use the canes. Now, I don't think about ALS every day. Every couple of days something happens and I think, `Oh, yeah, I have ALS.' "
Taubman Institute Director Dr. Eva Feldman received FDA approval in April to move the trial to Phase II, which will study efficacy as well as safety. Patient recruitment has not yet started for that phase of the trial.
Click here to read the entire Crain's blog post.
Dr. Eva Feldman: Alfred Taubman as mentor, leader, friend
The source of his greatness lay in his willingness to challenge conventional thinking.
WDIV covers institute's art + science program
Ch. 4 report profiles the collaboration between Taubman Scholar Tom Gardner and artist Osman Khan.
Taubman Scholars: Reflections on Alfred Taubman
Eminent scientists say his curiosity, interest and vision changed the course of medical science.
news & events
In the News
Taubman Emerging Scholar makes strides against cancer
Erika Newman, M.D., has identified a characteristic of deadly childhood neuroblastoma that may pave the way for more effective treatments.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.